4507

Shionogi & Co. Ltd.

4507.TSE shionogi.com
2,827.00
-4.00 (-0.14%)
JPY · TSE
52-week range
2,370.04
3,758.00
Trading at 33% of the 52-week range
Market Cap
2.41T
P/E Ratio
11.74
Forward P/E
15.41
Book Value
2,082.60
Div. Yield
2.49%
% Institutions
58.96%
% Insiders
4.84%

1 Year

+8.5%

3 Year

+37.1%

10 Year

+99.6%
Description

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

Company Information

Company Name
Shionogi & Co. Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
TSE
ISIN: JP3347200002
Currency: JPY
Full Time Employees: 6,223
Phone: 81 6 6202 2161
Fiscal Year End: March
IPO Date: May 01, 1949
Description:

Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.

Address:

Park Tower, Kita, Japan, 530-0011

People

Directors & Officers

Name Title Year Born
Dr. Isao Teshirogi Ph.D. CEO, President & Representative Director 1959
Dr. John Apeler Keller Ph.D. Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director 1964
Takuji Fujiwara Accounting & Finance Manager NA
Mr. Takeshi Shiota Ph.D. Corporate Officer and Senior VP of Corporate Quality Assurance, Ethics & Compliance Management Div. NA
Mr. Yoshimasa Kyokawa Vice President of Corporate Communications & Secretary Office NA
Yoshihiro Furuya Vice President of General Marketing and Compliance Officer of Corporate GXP Compliance Office NA
Mr. Kazuhiro Hatanaka Senior Executive Officer & Senior VP of Corporate Supervisory Unit NA
Akira Kato Ph.D. Senior Executive Officer & Senior VP of Supply Supervisory Unit NA
Mr. Toshinobu Iwasaki Ph.D. Senior Executive Officer & Senior VP of Healthcare Business Supervisory Unit NA
Masashi Deguchi Ph.D. Corporate Officer & Senior VP of Sustainability Management Division NA

Financial Highlights

Market Cap: $2,409.68B
EBITDA: $150.74B
P/E Ratio: $11.74
PEG Ratio: $0.66
Book Value: $2.08K
Dividend/Share: $71.00
Dividend Yield: 2.49%
Earnings/Share: $241.10
Profit Margin: 46.79%
Operating Margin: 11.42%
ROA (TTM): 3.22%
ROE (TTM): 16.77%
Revenue (TTM): $563.21B
Revenue/Share (TTM): $661.84
Earnings Growth (YOY): 148.20%
Revenue Growth (YOY): 63.70%

Valuation Metrics

Enterprise Value: $2,492.25B
Trailing P/E: 11.74
Forward P/E: 15.41

Shares Statistics

Shares Outstanding: 851.18M
Shares Float: 850.63M
% Insiders: 4.84%
% Institutions: 58.96%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$499.68B
Cost of Goods Sold
adjust
$-88.55B
Gross Profit
subtotal
$411.13B
SG&A
adjust
$-126.91B
R&D
adjust
$-122.84B
Operating Income
subtotal
$161.38B
Other / Non-Operating Items
adjust
$43.78B
Net Income
subtotal
$205.16B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about 4507.TSE!